Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been ...
Israel’s Cease-Fires in Lebanon and Gaza Appear Fragile Israeli forces killed at least 15 people and injured dozens more in southern Lebanon on Sunday, Lebanese officials said. In Gaza, Israel ...